Esperion Therapeutics (ESPR) Q2 2025 Earnings

6MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.33
-0.26
-0.18
-0.11

Details

Expected EPS
-0.154767
Actual EPS
-0.21
Surprise EPS
-0.06
Surprise Percent
+35.69%

Description

Esperion Therapeutics (ESPR) has reported earnings of -0.21 per share for Q2 2025.

0 Comments

Share your thoughts